Ravi madhusudana, Megha Krishnan, Vimarshitha P, Lakshya T, Dinesh C
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
An 70 year old female weighing 41kg and 151 cm tall came with complaints of mass per vagina since 10 years and discharge PV since 2 months. Patient gave history of cough for which pulmonologist opinion was taken and patient was started on Tab Montair LC 0-0-1 and Inj Hydrocort 100 mg 1-0-1. No other knowncomorbidities
Preop vitals were stable Preop investigations revealed a haemoglobin of 10.3 besides which rest all investigations were within normal limits. 2D echo revealed myxomatous Mitral valve with moderate MS; AV sclerotic with mild AR. Mild TR with mild PAH with PASP-50 mmhg and EF-55%. Cardiac opinion was sought and patient was deemed fit for surgery and to be taken under moderate risk. Inj LASIX 20 mg was advised 1hr prior to surgery. Pulmonologist also gave fitness and advised patient can be taken up for surgery under moderate risk. Primary anesthetic plan was under subarachnoid block and alternative was General anaesthesia
Preoperatively patient was given Tab Anxit 0.25 mg and Tab Rantac 150 mg. Nebulisation Duolin and Budecort was advised before shifting the patient to operation theatre. 1 pint PRBC was reserved. Preop Blood pressure was 140/80 mm hg. Intraop anaesthetic plan was changed to continous spinal anaesthesia Intrathecal catheter was inserted in L3-L4 space with the help of 18 G Touhys needle. Inj Bupivacaine 0.5% heavy-0.8cc was given initially at 10 am and a dose of inj Bupivacaine 0.5% heavy-0.6cc was repeated at 11:10 am. Patient maintained sensory block till T8. Patients vitals, urine output and blood loss was closely monitored and was uneventful.
Krishnan M, Madhusudhana R, Vimarshitha P, et al. A case of myxomatous mitral valve for hysterectomy managed with continuous spinal anaesthesia. Ind J Anesth Analg. 2026;13(1):54-6.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| October 18, 2025 | December 18, 2025 | March 30, 2026 |
Wednesday 17 June 2026, 01:50:21 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | October 18, 2025 |
| Accepted | December 18, 2025 |
| Published | March 30, 2026 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.